课题基金 / 基金详情

p53 Stabilization and Neurodegeneration

p53 Stabilization and Neurodegeneration
p53 稳定和神经变性
批准号:
6320244
负责人:
STEVEN Scott SCHREIBER
金额:
$31.19万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-04-01 至 2004-03-31

项目摘要

项目成果

STEVEN Scott SCHREIBER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(改编自申请人摘要):本项目的长期目标
英文摘要
DESCRIPTION (Adapted from applicant's abstract): The long-term goal of this project is to define the molecular mechanisms leading to tumor suppressor p53 accumulation and neuronal degeneration in the central nervous system. The application is based on novel findings obtained while conducting studies related to our previous NIH application. Activation of the p53 pathway has been strongly implicated in neuronal apoptosis in the mammalian central nervous system. In non-neural cells p53 abundance is tightly controlled by an inhibitory feedback loop involving the Mdm2 oncoprotein which binds to and targets p53 for ubiquitin-mediated degradation. However, the events responsible for p53 stabilization following DNA damage in neurons have not been delineated. Our preliminary studies demonstrate a novel mechanism of p53 accumulation due to down regulation of ubiquitin, as well as localization of p53 protein in the nucleolus of apoptotic neurons. The proposed studies will therefore use molecular and biochemical approaches to investigate the hypothesis that p53 stabilization is an essential component of certain types of neuronal degeneration mediated, in part, by impairment of nucleolar function. Specific Aim 1 will determine whether Mdm2 binding modulates p53 function, and will employ different approaches in animal and cell culture models to determine whether p53 accumulation is essential for neuronal cell death. Specific Aim 2 will investigate whether p53 regulates the ubiquitin-proteasome system. Specific Aim 3 will characterize the effect of p53 on nucleolar function in neuronal degeneration. Finally, Specific Aim 4 will determine whether neuronal death is prevented by restoring p53 degradation to vulnerable neurons. These studies should significantly add to our understanding of the molecular basis of certain types of neuronal cell death and the development of novel molecular and pharmacological interventions for neurodegenerative diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UBIQUITIN TRANSGENIC MICE, AGING AND NEURODEGENERATION
  • 批准号:
    6779453
  • 项目类别:
  • 资助金额:
    $6.82万
  • 财政年份:
    2004
  • 负责人:
    STEVEN Scott SCHREIBER
  • 依托单位:
UBIQUITIN TRANSGENIC MICE, AGING AND NEURODEGENERATION
  • 批准号:
    6890242
  • 项目类别:
  • 资助金额:
    $6.86万
  • 财政年份:
    2004
  • 负责人:
    STEVEN Scott SCHREIBER
  • 依托单位:
p53 Stabilization and Neurodegeneration
  • 批准号:
    6639755
  • 项目类别:
  • 资助金额:
    $26.51万
  • 财政年份:
    2001
  • 负责人:
    STEVEN Scott SCHREIBER
  • 依托单位:
p53 Stabilization and Neurodegeneration
  • 批准号:
    6540427
  • 项目类别:
  • 资助金额:
    $28.44万
  • 财政年份:
    2001
  • 负责人:
    STEVEN Scott SCHREIBER
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: